Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amphastar Pharma (NQ: AMPH ) 40.67 +1.06 (+2.68%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 331,883 Open 39.90 Bid (Size) 40.64 (2) Ask (Size) 40.68 (21) Prev. Close 39.61 Today's Range 39.46 - 40.84 52wk Range 36.56 - 67.66 Shares Outstanding 48,901,965 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 7 Biotech Stocks to Buy on the Dip: June 2024 June 24, 2024 With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation. Via InvestorPlace Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts June 18, 2024 These 2 small cap healthcare stocks could boom on a new sector breakout, Wall Street analysts see up to double-digit upside in each Via MarketBeat Topics ETFs Economy Exposures Interest Rates Performance YTD -34.71% -34.71% 1 Month +0.54% +0.54% 3 Month +1.24% +1.24% 6 Month -27.27% -27.27% 1 Year -32.98% -32.98% More News Read More Why the growth investor may take a look at NASDAQ:AMPH. June 05, 2024 Via Chartmill Amphastar Announces Additional $50 Million Increase to its Share Buyback Program June 04, 2024 Via ACCESSWIRE Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference June 03, 2024 Via ACCESSWIRE Exploring NASDAQ:AMPH's growth characteristics. May 15, 2024 Via Chartmill Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024 May 08, 2024 Via ACCESSWIRE NASDAQ:AMPH, an undervalued stock with good fundamentals. March 12, 2024 Via Chartmill Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol May 22, 2024 Via ACCESSWIRE Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade May 16, 2024 Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference May 09, 2024 Via ACCESSWIRE AMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca May 01, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023 February 28, 2024 Via ACCESSWIRE Delving into NASDAQ:AMPH's Growth Prospects. February 28, 2024 Via Chartmill Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024 April 30, 2024 Via ACCESSWIRE Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies April 10, 2024 Via Benzinga Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference April 01, 2024 Via ACCESSWIRE Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference March 06, 2024 Via ACCESSWIRE Earnings Outlook For Amphastar Pharma February 27, 2024 Via Benzinga Is NASDAQ:AMPH a Fit for Growth Investing Strategies? February 14, 2024 Via Chartmill Is NASDAQ:AMPH a Fit for Growth Investing Strategies? February 07, 2024 Via Chartmill Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024 February 20, 2024 Via ACCESSWIRE CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+ February 13, 2024 Via Investor's Business Daily 3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential February 05, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.